BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4107104)

  • 1. [Clinical and cysto-sphincterometric results of progestogen therapy of prostatic adenoma].
    Makrigiannis D; Gaca AH
    Clin Ter; 1971 Jun; 57(5):399-416. PubMed ID: 4107104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate].
    Nagel R; Hargenda B
    Hinyokika Kiyo; 1970 Sep; 16(9):423-8. PubMed ID: 4097356
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal treatment of prostatic hypertrophy with special reference to the usefulness of gestagens].
    Musierowicz A
    Wiad Lek; 1974 Nov; 27(22):1985-8. PubMed ID: 4140619
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gestagens--an effective conservative treatment of the so-called prostatic hypertrophy?].
    Reichelt H
    Wien Med Wochenschr; 1970 Nov; 120(45):792-5. PubMed ID: 4103896
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gestagens: a new method of hormonal therapy in benign prostatic hypertrophy].
    Vernet D
    Urol Int; 1970; 25(3):263-8. PubMed ID: 4112432
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with SH-582 for prostatic hypertrophy with special reference to its effects on the thyroid function].
    Kuroda K; Nakamura T; Wada I
    Hinyokika Kiyo; 1970 Sep; 16(9):482-8. PubMed ID: 4097360
    [No Abstract]   [Full Text] [Related]  

  • 8. [The clinical effects of SH 582 (gestonorone caproate) on benign prostatic hypertrophy].
    Momose S; Hidaka M; Oota Y; Oomaru K
    Hinyokika Kiyo; 1970 Sep; 16(9):551-4. PubMed ID: 4097366
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progestogen therapy of benign prostatic hypertrophy].
    Nakayama K; Okamoto K
    Hinyokika Kiyo; 1970 Sep; 16(9):558-60. PubMed ID: 4097367
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progestogen therapy for prostatic hypertrophy].
    Tabayashi Y; Kawabata T; Sasaki H
    Hinyokika Kiyo; 1970 Sep; 16(9):459-72. PubMed ID: 4097964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of SH 582 (gestonorone caproate) for prostatic hypertrophy].
    Ochiai K; Komase M; Oshima H; Negishi T; Yamauchi A
    Hinyokika Kiyo; 1970 Sep; 16(9):473-81. PubMed ID: 4097359
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate.
    Scott WW; Wade JC
    J Urol; 1969 Jan; 101(1):81-5. PubMed ID: 4178189
    [No Abstract]   [Full Text] [Related]  

  • 13. Gestronol hexanoate (SH582) and benign prostatic hypertrophy.
    Pitchford AG
    Proc R Soc Med; 1972 Feb; 65(2):128-9. PubMed ID: 4117436
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of 17-alpha-hydroxy-19-norprogesterone acaproate (SH-582) on prostatic hypertrophy with special reference to estimation of size of the prostate by means of ultrasonotomography].
    Watanabe H; Kaiho H; Takahashi H; Kato T; Shima M
    Hinyokika Kiyo; 1970 Sep; 16(9):438-45. PubMed ID: 4097357
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the treatment of prostatic adenoma with hydroxyprogesterone caronate].
    Ibba AL
    Osp Ital Chir; 1968; 19(4):427-42. PubMed ID: 4180617
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with SH 582 for prostatic hypertrophy; comparison with estrogen therapy].
    Terao N; Ogawa I; Fujimura N; Kondo K; Tsumagari I
    Hinyokika Kiyo; 1970 Sep; 16(9):523-30. PubMed ID: 4097364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
    Magyarsóky F
    Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of prostatic hypertrophy with depostat].
    Nuri M; Hochberg K
    Munch Med Wochenschr; 1970 May; 112(22):1057-60. PubMed ID: 4192989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with SH 582 for prostatic hypertrophy].
    Kobayashi C; Miki M
    Hinyokika Kiyo; 1970 Sep; 16(9):446-9. PubMed ID: 4097358
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonoperative management of senile prostatic hyperplasia.
    Fam A
    Int Surg; 1971 Oct; 56(4):252-9. PubMed ID: 4106484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.